Back to Search Start Over

A novel 3D culture model recapitulates primary FL B-cell features and promotes their survival.

Authors :
Lamaison C
Latour S
Hélaine N
Le Morvan V
Saint-Vanne J
Mahouche I
Monvoisin C
Dussert C
Andrique L
Deleurme L
Dessauge E
Pangault C
Baulande S
Legoix P
Seffals M
Broca-Brisson L
Alessandri K
Carlotti M
Soubeyran P
Merlio JP
Mourcin F
Nassoy P
Recher G
Tarte K
Bresson-Bepoldin L
Source :
Blood advances [Blood Adv] 2021 Dec 14; Vol. 5 (23), pp. 5372-5386.
Publication Year :
2021

Abstract

Non-Hodgkin B-cell lymphomas (B-NHL) mainly develop within lymph nodes as aggregates of tumor cells densely packed with their surrounding microenvironment, creating a tumor niche specific to each lymphoma subtypes. In vitro preclinical models mimicking biomechanical forces, cellular microenvironment, and 3D organization of B-cell lymphomas remain scarce, while all these parameters are key determinants of lymphomagenesis and drug resistance. Using a microfluidic method based on cell encapsulation inside permeable, elastic, and hollow alginate microspheres, we developed a new tunable 3D model incorporating lymphoma B cells, extracellular matrix (ECM), and/or tonsil stromal cells (TSC). Under 3D confinement, lymphoma B cells were able to form cohesive spheroids resulting from overexpression of ECM components. Moreover, lymphoma B cells and TSC dynamically formed self-organized 3D spheroids favoring tumor cell growth. 3D culture induced resistance to the classical chemotherapeutic agent doxorubicin, but not to the BCL2 inhibitor ABT-199, identifying this approach as a relevant in vitro model to assess the activity of therapeutic agents in B-NHL. RNA-sequence analysis highlighted the synergy of 3D, ECM, and TSC in upregulating similar pathways in malignant B cells in vitro than those overexpressed in primary lymphoma B cells in situ. Finally, our 3D model including ECM and TSC allowed long-term in vitro survival of primary follicular lymphoma B cells. In conclusion, we propose a new high-throughput 3D model mimicking lymphoma tumor niche and making it possible to study the dynamic relationship between lymphoma B cells and their microenvironment and to screen new anti-cancer drugs.<br /> (© 2021 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.)

Details

Language :
English
ISSN :
2473-9537
Volume :
5
Issue :
23
Database :
MEDLINE
Journal :
Blood advances
Publication Type :
Academic Journal
Accession number :
34555842
Full Text :
https://doi.org/10.1182/bloodadvances.2020003949